Skip to main content
Clinical Trials/NCT01513915
NCT01513915
Completed
N/A

A Parent-only Group Cognitive Behavioral Intervention for Children With Anxiety Disorders: a Control Waiting List Group Study

Tehran University of Medical Sciences1 site in 1 country40 target enrollmentJuly 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anxiety Disorders
Sponsor
Tehran University of Medical Sciences
Enrollment
40
Locations
1
Primary Endpoint
Revised Children's Manifest Anxiety (RCMA)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The fact that Cognitive Behavioral Therapy (CBT) is a well known efficacious intervention for children with anxiety disorders (AD) is undeniable. However, most children with AD have limited access to CBT. There is some controversial evidence on group CBT in AD involving families in treatment of their children and a published article on efficacy of a parent only group CBT for these children. Considering these data, the investigators hypothesized that teaching anxiety-fighting skills to parents of children with AD would diminish anxiety symptoms of both parents and children and improve family relational functioning.

Detailed Description

All children and their parents were interviewed using K-SADS-PL-Persian Version, a semi-structured diagnostic interview to confirm the diagnoses and assess possible comorbidities. All diagnostic assessments were conducted by a fellowship of child and adolescent psychiatry. Following assessment, once the participants reached twenty members, they were invited to complete child and parent self-report measures. The level of child functioning and family relationship functioning were also evaluated. Then they were randomly allocated to either parent training (N=20) or a 6 week wait-list (N=22) groups. During 2 weeks after treatment the assessments were repeated and satisfaction ratings were collected for the intervention group.

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
July 2009
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zahra Shahrivar

Assistant Professor

Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • having DSM-IV criteria for a primary diagnosis of generalized anxiety disorder (GAD), separation anxiety disorder (SAD), social phobia, or specific phobia.
  • age 6 to 12 years,
  • receiving one of selective serotonin reuptake inhibitor (SSRI) medicine at the stable dose for at least 8 weeks before baseline assessments and during the study,
  • at least one parent willing to participate and give written consent.

Exclusion Criteria

  • diagnosed as bipolar disorder, autism spectrum disorders or mental disability by data obtained in personal history and clinical assessments,
  • there was a change in drug regime during the study period,
  • if parents missed more than 2 of 6 sessions of treatment.

Outcomes

Primary Outcomes

Revised Children's Manifest Anxiety (RCMA)

Time Frame: up to 30 minutes

This self report questionnaire consists of 28 items assessing a child's chronic or trait anxiety and 9 items assessing social desirability or potential lying. The RCMA has achieved a high internal consistency and moderate test-retest reliability.

Secondary Outcomes

  • Assessment of Consumer Satisfaction(25 minutes)
  • Depression-Anxiety-Stress Scale (DASS)(20 minutes)
  • Children Global Assessment Scale (CGAS)(15 minutes)
  • Children's Depression Inventory (CDI)(20 minutes)
  • Strengths and Difficulties Questionnaire (SDQ) Home Version([Time Frame: 30 minutes])
  • Global Relational Assessment of Functioning (GRAF)([Time Frame: 15 minutes])

Study Sites (1)

Loading locations...

Similar Trials